Dr. Marc Fiume is an entrepreneur, researcher, and thought-leader in genomics and clinical data sharing. Marc is the Co-founder and CEO of DNAstack, a Toronto-based software company that technologies that accelerate collaborative biomedical research, supported by major cloud providers and academic and clinical research partners around the world. Marc co-chairs the Discovery Work Stream for the Global Alliance for Genomics & Health, which develops open and interoperable standards to enable real-time search engines across globally federated biomedical data. His team develops the Beacon Network, the world’s largest search engine for public sharing of genomic mutations, which has facilitated millions of searches and has led to disease-gene discoveries and clinical translation.
Artificial intelligence holds the promise to revolutionize health care and directly impact the clinical trials process via expediting the recruitment of eligible clinical trial patients. The systems currently developed with the use of AI/ML enable higher patient enrollment rates and better trial assignment, contribute to reducing the cost of recruitment via additional/more efficient medical tests, and facilitate analysis and integration of operational data from historical cases. This session focuses on various applications of AI in clinical trial design and patient selection.